A Patient Presents with Longstanding, Severe LV Dysfunction. Is There a Role for Additional Risk Stratification Before ICD?

Larisa G. Tereshchenko; Ronald D. Berger

doi:10.1016/j.ccep.2012.02.011

A Patient Presents with Longstanding, Severe LV Dysfunction. Is There a Role for Additional Risk Stratification Before ICD?

Larisa G. Tereshchenko, Ronald D. Berger

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

Increased longevity of patients with systolic heart failure caused by the use of implantable cardioverter-defibrillators (ICDs) is one of the most successful achievements in contemporary medicine. During the last 2 decades, the scientific community has striven to increase the benefits of ICD usage by specifying indications for primary prevention ICD implantation. Left ventricular ejection fraction is neither highly specific nor is it a highly sensitive risk marker of sudden cardiac death. The authors discuss risk-stratification approaches in different patient populations with structural heart disease and systolic heart failure.

Original language	English (US)
Pages (from-to)	151-160
Number of pages	10
Journal	Cardiac Electrophysiology Clinics
Volume	4
Issue number	2
DOIs	https://doi.org/10.1016/j.ccep.2012.02.011
State	Published - Jun 2012
Externally published	Yes

Keywords

Implantable cardioverter-defibrillator
Left ventricular systolic dysfunction
Primary prevention
Risk stratification
Sudden cardiac arrest

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1016/j.ccep.2012.02.011

Cite this

@article{ef4789f7c4ae44b1822dbd19560bb598,

title = "A Patient Presents with Longstanding, Severe LV Dysfunction. Is There a Role for Additional Risk Stratification Before ICD?",

abstract = "Increased longevity of patients with systolic heart failure caused by the use of implantable cardioverter-defibrillators (ICDs) is one of the most successful achievements in contemporary medicine. During the last 2 decades, the scientific community has striven to increase the benefits of ICD usage by specifying indications for primary prevention ICD implantation. Left ventricular ejection fraction is neither highly specific nor is it a highly sensitive risk marker of sudden cardiac death. The authors discuss risk-stratification approaches in different patient populations with structural heart disease and systolic heart failure.",

keywords = "Implantable cardioverter-defibrillator, Left ventricular systolic dysfunction, Primary prevention, Risk stratification, Sudden cardiac arrest",

author = "Tereshchenko, {Larisa G.} and Berger, {Ronald D.}",

note = "Funding Information: Disclosures: Larisa G. Tereshchenko discloses research grant support from Medtronic, Inc, Boston Scientific , and St Jude Foundation , and a consultant fee from Boston Scientific. Ronald D. Berger holds a patent on QT variability technology. ",

year = "2012",

month = jun,

doi = "10.1016/j.ccep.2012.02.011",

language = "English (US)",

volume = "4",

pages = "151--160",

journal = "Cardiac Electrophysiology Clinics",

issn = "1877-9182",